These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 19641884)

  • 1. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
    Lee MS; Lee YJ; Kim BJ; Shin KJ; Chung BC; Baek DJ; Jung BH
    Arch Pharm Res; 2009 Jul; 32(7):1029-35. PubMed ID: 19641884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
    Tang W; Borel AG; Fujimiya T; Abbott FS
    Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of thiol-conjugated metabolites of 2-propylpent-4-enoic acid (4-ene VPA), a toxic metabolite of valproic acid, by electrospray tandem mass spectrometry.
    Tang W; Abbott FS
    J Mass Spectrom; 1996 Aug; 31(8):926-36. PubMed ID: 8799319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative investigation of 2-propyl-4-pentenoic acid (4-ene VPA) and its alpha-fluorinated analogue: phase II metabolism and pharmacokinetics.
    Tang W; Abbott FS
    Drug Metab Dispos; 1997 Feb; 25(2):219-27. PubMed ID: 9029053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high-dose valproic acid in rats.
    Jung BH; Kim BJ; Lee MS; Lee JH; Oh JH; Lee YJ
    J Appl Toxicol; 2010 Nov; 30(8):775-8. PubMed ID: 21157986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
    Tong V; Teng XW; Chang TK; Abbott FS
    Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
    Tang W; Abbott FS
    Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics study with gas chromatography-mass spectrometry for predicting valproic acid-induced hepatotoxicity and discovery of novel biomarkers in rat urine.
    Lee MS; Jung BH; Chung BC; Cho SH; Kim KY; Kwon OS; Nugraha B; Lee YJ
    Int J Toxicol; 2009; 28(5):392-404. PubMed ID: 19605889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility.
    El-Mowafy AM; Abdel-Dayem MA; Abdel-Aziz A; El-Azab MF; Said SA
    Biochim Biophys Acta; 2011; 1811(7-8):460-7. PubMed ID: 21571092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.
    Löscher W; Wahnschaffe U; Hönack D; Wittfoht W; Nau H
    Epilepsy Res; 1992 Dec; 13(3):187-98. PubMed ID: 1493781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chronic hepatic failure on disposition kinetics of valproate excretion through a phase II reaction in rats treated with carbon tetrachloride.
    Khemawoot P; Maruyama C; Tsukada H; Noda H; Ishizaki J; Yokogawa K; Miyamoto K
    Biopharm Drug Dispos; 2007 Sep; 28(6):331-8. PubMed ID: 17617793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K; Farrell K; Abbott F
    Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes.
    Jurima-Romet M; Abbott FS; Tang W; Huang HS; Whitehouse LW
    Toxicology; 1996 Aug; 112(1):69-85. PubMed ID: 8792850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of N-acetylcysteine conjugates of valproic acid in humans and animals.
    Gopaul SV; Farrell K; Abbott FS
    Drug Metab Dispos; 2000 Jul; 28(7):823-32. PubMed ID: 10859157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of valproate dose on formation of hepatotoxic metabolites.
    Anderson GD; Acheampong AA; Wilensky AJ; Levy RH
    Epilepsia; 1992; 33(4):736-42. PubMed ID: 1628592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
    Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: Role of biotransformation and temporal relationship with onset of toxicity.
    Kiang TK; Teng XW; Surendradoss J; Karagiozov S; Abbott FS; Chang TK
    Toxicol Appl Pharmacol; 2011 May; 252(3):318-24. PubMed ID: 21397622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of teratogenicity of trans-2-ene-valproic acid compared to valproic acid in rats.
    Vorhees CV; Acuff-Smith KD; Weisenburger WP; Minck DR; Berry JS; Setchell KD; Nau H
    Teratology; 1991 Jun; 43(6):583-90. PubMed ID: 1882349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-induced liver injury: modulation by the omega-3 fatty acid DHA proposes a novel anticonvulsant regimen.
    Abdel-Dayem MA; Elmarakby AA; Abdel-Aziz AA; Pye C; Said SA; El-Mowafy AM
    Drugs R D; 2014 Jun; 14(2):85-94. PubMed ID: 24733439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.